<DOC>
	<DOCNO>NCT01841814</DOCNO>
	<brief_summary>The purpose study ass change bone mineral density ( BMD ) 12 month therapeutic management patient lymphoma .</brief_summary>
	<brief_title>Evolution Bone Mineral Density ( BMD ) Patients With Lymphoma Undergoing Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Subjects age 18 80 lymphoma , Histological diagnosis Hodgkin 's lymphoma ( HL ) nonHodgkin lymphoma ( NHL ) follicular aggressive ( large cell ) , Patients yet start chemotherapy start less month Patient sign informed consent . Pathological fracture time initial diagnosis lymphoma , Compression neurological epidural , Patients receive treatment osteoporosis ( include bisphosphonates , selective modulators estrogen receptor , calcitonin parathyroid hormone Teriparatide ) . Discovery osteoporosis osteopenia fracture initial evaluation require establishment osteoporosis treatment , Radiotherapy lumbar spine hip study , Location bone lymphoma lumbar spine hip study , History disorder affect bone metabolism ( prostate cancer androgen , stomach cancer , hyperparathyroidism , hyperthyroidism , uncontrolled ... ) A person incapable give consent personally , Pregnant breastfeed woman , Protected Person ( guardianship ) Patient affiliate social security system .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Patient</keyword>
</DOC>